ESMC Schedule 13G/A filed by Charles C. Newton shows zero ownership

Rhea-AI Filing Summary

Escalon Medical Corp (ESMC) Schedule 13G/A filed by Charles C. Newton reports zero beneficial ownership of the issuer's common stock. The filing states the reporting person holds 0 shares, representing 0 of the class, and discloses no voting or dispositive power over any shares. The form affirms the securities were not acquired to influence control of the issuer and includes a certification of accuracy signed by Charles C. Newton on 10/06/2025.

Positive

• Clear disclosure of zero beneficial ownership and zero voting/dispositive power
• Signed certification affirming securities were not acquired to influence control dated 10/06/2025
• Complete identifying details including CUSIP 296074305 and reporter name/address

Negative

• None.

Insights

Corporate Governance Analyst

TL;DR: The filing documents no ownership and affirms no control intent.

The filing shows the reporting person, Charles C. Newton, holds 0 shares and 0 ownership, so there is no change to the shareholder register or control structure.

This is a routine disclosure; investors should note there is no evidence here of an activist or control stake and no transaction to monitor in the near term.

Regulatory Compliance Specialist

TL;DR: Submission meets Schedule 13G/A formal requirements and includes a certification.

The statement includes required identifying information, CUSIP 296074305, and a signed certification dated 10/06/2025. It checks ownership boxes showing 0 voting and dispositive power.

From a compliance standpoint, the filing appears complete and self‑certifies that the securities were not acquired to influence control; no further disclosures are indicated here.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

ESCALON MEDICAL CORP

(Name of Issuer)

Common Stock

(Title of Class of Securities)

296074305

(CUSIP Number)

10/06/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 296074305

1

Names of Reporting Persons

Newton Charles Carter

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.0 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: ESCALON MEDICAL CORP
(b)	Address of issuer's principal executive offices: 435 DEVON PARK ROAD, SUITE 824, WAYNE, PENNSYLVANIA, 19087
Item 2.
(a)	Name of person filing: Charles C Newton
(b)	Address or principal business office or, if none, residence: 1159 EAST KESWICK DR. KESWICK, VA 22947
(c)	Citizenship: USA
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 296074305
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 0
(b)	Percent of class: 0 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Newton Charles Carter

Signature:	Charles C Newton
Name/Title:	Self
Date:	10/06/2025

FAQ

What does the Schedule 13G/A filed by Charles C. Newton for ESMC report?

The filing reports 0 shares beneficially owned, representing 0 of the class, with no voting or dispositive power.

When was the Schedule 13G/A for Escalon Medical (ESMC) signed?

The certification is signed by Charles C. Newton on 10/06/2025.

Does this filing indicate an intent to influence control of Escalon Medical?

No. The filer certifies the securities were not acquired and are not held to change or influence control of the issuer.

What identifying information is included in the filing?

The filing lists the issuer address (435 Devon Park Road, Wayne, PA), CUSIP 296074305, and the reporting person’s name and residence.

Does the Schedule 13G/A show ownership on behalf of others or group membership?

No. The filing states Not Applicable for ownership on behalf of another person and does not identify any group.